- Home
- USAR vs MDXG Comparison
USAR vs MDXG Comparison
Compare USAR & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- USAR
- MDXG
- Stock Information
- Founded
- USAR 2019
- MDXG 2006
- Country
- USAR United States
- MDXG United States
- Employees
- USAR N/A
- MDXG N/A
- Industry
- USAR
- MDXG Biotechnology: Pharmaceutical Preparations
- Sector
- USAR
- MDXG Health Care
- Exchange
- USAR NYSE
- MDXG Nasdaq
- Market Cap
- USAR 1.2B
- MDXG 999.9M
- IPO Year
- USAR N/A
- MDXG N/A
- Fundamental
- Price
- USAR $10.52
- MDXG $6.23
- Analyst Decision
- USAR Strong Buy
- MDXG Strong Buy
- Analyst Count
- USAR 2
- MDXG 2
- Target Price
- USAR $16.00
- MDXG $12.50
- AVG Volume (30 Days)
- USAR 3.1M
- MDXG 614.4K
- Earning Date
- USAR 08-15-2025
- MDXG 07-30-2025
- Dividend Yield
- USAR N/A
- MDXG N/A
- EPS Growth
- USAR N/A
- MDXG N/A
- EPS
- USAR 0.13
- MDXG 0.27
- Revenue
- USAR N/A
- MDXG $352,375,000.00
- Revenue This Year
- USAR N/A
- MDXG $9.55
- Revenue Next Year
- USAR N/A
- MDXG $11.43
- P/E Ratio
- USAR $79.46
- MDXG $22.93
- Revenue Growth
- USAR N/A
- MDXG 5.34
- 52 Week Low
- USAR $5.56
- MDXG $5.47
- 52 Week High
- USAR $20.00
- MDXG $10.14
- Technical
- Relative Strength Index (RSI)
- USAR N/A
- MDXG 49.01
- Support Level
- USAR N/A
- MDXG $5.86
- Resistance Level
- USAR N/A
- MDXG $6.42
- Average True Range (ATR)
- USAR 0.00
- MDXG 0.22
- MACD
- USAR 0.00
- MDXG 0.05
- Stochastic Oscillator
- USAR 0.00
- MDXG 69.84
About USAR USA RARE EARTH INC
USA Rare Earth Inc is a vertically integrated, domestic rare earth magnet supply chain that supports the state of energy, mobility, and national security in the United States. USARE is developing an NdFeB magnet manufacturing plant in the United States, and establishing domestic rare earth and critical minerals supply, extraction, and processing capabilities to both supply its manufacturing plant and market surplus materials to third parties. Rare earth magnets are critical to various business sectors and industries, including the defense, automotive, aviation, industrial, medical and consumer electronics industries.
About MDXG MiMedx Group Inc
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.